ask="N/A"
ask_size="N/A"
average_daily_volume="118115"
bid="N/A"
bid_size="N/A"
book_value="0.444"
change="+0.012"
change_from_200_day_moving_average="-0.290"
change_from_50_day_moving_average="0.031"
change_from_52_week_high="-1.608"
change_From_52_week_low="0.242"
change_in_percent="+0.609%"
close="1.982"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.356"
ebitda="-8.62M"
eps_estimate_current_year="-0.310"
eps_estimate_next_quarter="-0.060"
eps_estimate_next_year="-0.330"
ex_dividend_date="N/A"
float_shares="13184000"
high="2.000"
high_52_weeks="3.590"
last_trade_date="3/9/2017"
last_trade_price="1.982"
last_trade_size="100"
last_trade_time="4:02pm"
low="1.950"
low_52_weeks="1.740"
market_capitalization="26.52M"
moving_average_200_day="2.272"
moving_average_50_day="1.951"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.000"
open="1.950"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-12.765%"
percent_change_from_50_day_moving_average="+1.567%"
percent_change_from_52_week_high="-44.791%"
percent_change_from_52_week_low="+13.908%"
previous_close="1.970"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.437"
price_per_sales="130.590"
revenue="201827.00"
shares_outstanding="13379000"
short_ratio="1.110"
stock_exchange="ASE"
symbol="CANF"
volume="32251"
weeks_range_52="1.740 - 3.590"
